JAN (NYSE:JAN - Get Free Report) was upgraded by research analysts at Wall Street Zen from a "sell" rating to a "hold" rating in a report released on Saturday.
JAN has been the topic of several other research reports. Raymond James Financial began coverage on JAN in a research report on Tuesday, June 16th. They issued a "strong-buy" rating and a $34.00 price objective on the stock. BNP Paribas Exane assumed coverage on JAN in a research report on Tuesday, April 14th. They set an "outperform" rating and a $27.00 target price for the company. UBS Group set a $29.00 target price on JAN in a research note on Thursday, June 18th. Morgan Stanley began coverage on shares of JAN in a research report on Tuesday, April 14th. They set an "overweight" rating and a $28.00 price target for the company. Finally, Bank of America started coverage on shares of JAN in a report on Tuesday, April 14th. They set a "buy" rating and a $29.00 price objective for the company. Two equities research analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and two have assigned a Hold rating to the company's stock. According to MarketBeat, JAN has a consensus rating of "Buy" and an average target price of $29.85.
Read Our Latest Research Report on JAN
JAN Stock Performance
JAN stock opened at $30.50 on Friday. JAN has a 52 week low of $22.76 and a 52 week high of $32.83. The business's 50 day moving average price is $28.36. The company has a market cap of $8.03 billion and a PE ratio of -610.02.
JAN (NYSE:JAN - Get Free Report) last released its earnings results on Tuesday, May 5th. The company reported $0.23 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.23. The business had revenue of $200.35 million during the quarter, compared to the consensus estimate of $157.96 million. As a group, sell-side analysts expect that JAN will post 0.97 EPS for the current fiscal year.
JAN News Roundup
Here are the key news stories impacting JAN this week:
- Positive Sentiment: Cantor Fitzgerald raised its price target on JAN to $34 from $30 and maintained an “Overweight” rating. The revised target implies approximately 11.7% upside from the referenced $30.44 price, providing a fresh bullish catalyst. JAN price target increase
- Positive Sentiment: Janus Living’s recent earnings discussion emphasized expansion without long-term debt, which may be reinforcing investor confidence in the company’s ability to grow while limiting balance-sheet risk. Janus Living boosts outlook on debt-free growth
- Positive Sentiment: The company’s latest reported quarter also provided support: JAN earned $0.23 per share, in line with estimates, while revenue of $200.4 million exceeded consensus of $158.0 million.
- Neutral Sentiment: Despite the improved target, JAN remains a growth-oriented stock with a negative reported P/E ratio, so investors will likely continue focusing on revenue growth, profitability, cash generation and execution of its expansion plans.
About JAN
(
Get Free Report)
Upon completion of this offering, we will be the only U.S. publicly traded REIT focused exclusively on the senior housing sector and the only U.S. publicly traded REIT whose entire portfolio is owned and operated under RIDEA structures. We have an initial portfolio consisting of 34 senior housing communities, comprised of 10,422 units as of December 31, 2025. Our communities are located primarily in major retirement markets across 10 states, with units in Florida and Texas representing 69% of the total units as of December 31, 2025.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider JAN, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and JAN wasn't on the list.
While JAN currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.